Trial Profile
SCH 486757 vs Codeine and Placebo in Subjects With Persistent Postviral Cough
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 06 May 2022
Price :
$35
*
At a glance
- Drugs SCH 486757 (Primary) ; Codeine
- Indications Cough
- Focus Therapeutic Use
- Sponsors Merck Sharp & Dohme Corp.
- 28 Mar 2014 New trial record